Kamal Dua

Predictive genomic tools in disease stratification and targeted prevention: a recent update in personalized therapy advancements

D. Chellappan, Upendra Nagaich, K. Dua, 2022, EPMA Journal.

MicroRNA-125a/b Inhibits A20 and MAVS to Promote Inflammation and 3 Impair Antiviral Response in Chronic Obstructive Pulmonary Disease

S. Grey, P. Foster, K. Baines, 2021 .

Vitamin D, Calbindin, and calcium signaling: Unraveling the Alzheimer's connection.

D. Chellappan, G. Gupta, M. Tambuwala, 2024, Cellular signalling.

Tea (Catechins Including (−)-Epigallocatechin-3-gallate) and Cancer

Hari Prasad Devkota, N. Panth, D. Chellappan, 2021, Food Bioactive Ingredients.

Recent advances in cancer therapy using PARP inhibitors

D. Chellappan, M. Tambuwala, A. Aljabali, 2022, Medical Oncology.

Cellular probing using phytoceuticals encapsulated advanced delivery systems in ameliorating lung diseases: Current trends and future prospects.

K. Paudel, Gabriele De Rubis, B. Oliver, 2024, International immunopharmacology.

Exploring the anti-inflammatory and anti-fibrotic activity of NFκB decoy oligodeoxynucleotide-loaded spermine-functionalized acetalated nanoparticles.

P. Hansbro, K. Paudel, C. Samuel, 2024, Chemico-biological interactions.

Anti-inflammatory and anti-fibrotic effects of berberine-loaded liquid crystalline nanoparticles

D. Chellappan, P. Hansbro, K. Paudel, 2023, EXCLI journal.